NCT00534820

Brief Summary

Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2004

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

September 24, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 26, 2007

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

December 17, 2015

Status Verified

December 1, 2015

Enrollment Period

9.2 years

First QC Date

September 24, 2007

Last Update Submit

December 16, 2015

Conditions

Lymphoma, Non-HodgkinHodgkin Disease

Keywords

Cytogenetic Analysis of Bone Marrow Specimen in Non-Hodgkin's Lymphoma or Hodgkin's Disease

Outcome Measures

Primary Outcomes (1)

  • Efficacy

    6 years

Interventions

Cytogenetic Analysis of Bone Marrow SpecimenPROCEDURE

Cytogenetic Analysis of BM Specimen

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KFSH&RC

Riyadh, 11211, Saudi Arabia

Location

MeSH Terms

Conditions

Lymphoma, Non-HodgkinHodgkin Disease

Condition Hierarchy (Ancestors)

LymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Syed Akhtar, MD

    KFSH&RC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 24, 2007

First Posted

September 26, 2007

Study Start

June 1, 2004

Primary Completion

August 1, 2013

Study Completion

August 1, 2013

Last Updated

December 17, 2015

Record last verified: 2015-12

Locations

SA(1)